Analysing the effects of National Centralised Drug Procurement and Price Negotiation Policies on novel hypoglycaemic drug usage and costs in Shanghai, China: an interrupted time series analysis
Implementation of NDPN and NCDP had successfully cut-off the price of novel hypoglycaemic drugs and significantly increased their utilisation. In the future, the government needs to control pharmaceutical expenses more strictly while ensuring the rational use of the drugs.
Authors
- Hai Lin (ORCID: https://orcid.org/0000-0002-0878-137X)
- Chunlin Jin (ORCID: https://orcid.org/0000-0003-4496-9166)
- Xu Yuan (ORCID: https://orcid.org/0000-0003-3775-3033)
- Jie Song (ORCID: https://orcid.org/0009-0008-1610-9648)
- Guo Wei (ORCID: https://orcid.org/0000-0001-9638-1853)
- Xiaojing Hu (ORCID: https://orcid.org/0000-0003-0537-7475)
- Zheng Zhang (ORCID: https://orcid.org/0009-0006-9558-6535)
Institutions
- Shanghai University (CN)
- Second Military Medical University (CN)
- Renji Hospital (CN)
- Shanghai Medical Information Center (CN)
- Development Research Center (CN)
Publication Details
- Journal
- BMJ Open
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1136/bmjopen-2024-088318
- Citations
- 4
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Science and Technology Commission of Shanghai Municipality